Publication | Open Access

First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial

Lymphoid NeoplasiaMedicineImmunologyPathologyLymphatic DiseaseImmunotherapyOncologyRadiation OncologyFirst-line Response-adapted Treatment